Chiu Chang-Fang, Wang Hwei-Chung, Wang Chung-Hsing, Wang Cheng-Li, Lin Cheng-Chieh, Shen Chen-Yang, Chiang Su-Yin, Bau Da-Tian
Department of Hematology Oncology, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Anticancer Res. 2008 Jan-Feb;28(1A):267-70.
The DNA repair gene XRCC4, an important caretaker of the overall genome stability, is thought to play a major role in the human carcinogenesis. Some new and important polymorphic variants of XRCC4, at codon 247 (rs 3734091), G-1394T (rs 6869366), and Intron 7 (rs 28360317), and their association with breast cancer susceptibility was investigated in a Taiwanese population.
In a hospital-based case-control study, 432 female patients with breast cancer and 432 age-matched healthy controls recruited from the China Medical Hospital in Central Taiwan were genotyped.
A significant difference in the frequency of the XRCC4 G-1394T genotype, but not the XRCC4 codon 247, or intron 7 genotypes was found between the breast cancer and control groups. Individuals with G/T or T/T at the XRCC4 G-1394T locus showed a 2.33-fold (95% confidence interval=1.37-3.98) increased risk of breast cancer compared to those with G/G. For XRCC4 codon 247 or intron 7, there was no difference in distribution between the breast cancer and control groups.
Our findings suggest that the heterozygous and homozygous T allele of the XRCC4 G-1394T may be associated with the development of breast cancer and may be a useful biomarker for anticancer prevention and intervention.
DNA修复基因XRCC4是整体基因组稳定性的重要守护者,被认为在人类致癌过程中起主要作用。在台湾人群中研究了XRCC4的一些新的重要多态性变体,位于密码子247(rs 3734091)、G - 1394T(rs 6869366)和内含子7(rs 28360317),以及它们与乳腺癌易感性的关联。
在一项基于医院的病例对照研究中,对从台湾中部中国医药大学招募的432例女性乳腺癌患者和432例年龄匹配的健康对照进行基因分型。
在乳腺癌组和对照组之间,发现XRCC4 G - 1394T基因型的频率存在显著差异,但XRCC4密码子247或内含子7基因型无差异。与G/G基因型个体相比,XRCC4 G - 1394T位点为G/T或T/T的个体患乳腺癌的风险增加了2.33倍(95%置信区间 = 1.37 - 3.98)。对于XRCC4密码子247或内含子7,乳腺癌组和对照组之间的分布没有差异。
我们的研究结果表明,XRCC4 G - 1394T的杂合和纯合T等位基因可能与乳腺癌的发生有关,可能是抗癌预防和干预的有用生物标志物。